Medical supplies Korean listed companies

Grouped by the industry code each company registered with DART. Sorted by latest quarterly operating profit.

Companies32
Operating profit₩42.7bnlatest quarter, combined
Operating losses17
Average dividend yield2.4%8 payers

There are 32 KOSPI and KOSDAQ companies classified under medical supplies. Combined operating profit for the latest reported quarter across 27 of them was ₩42.7bn; 17 posted an operating loss and 1 swung to a profit from a loss a year earlier. The largest by quarterly operating profit were PharmaResearch, T&L and Boditech Med. The median operating margin across the 26 with reported revenue was -4.0%. 8 paid a cash dividend, with an average reported yield of 2.4%.

Medical supplies companies

CompanyLatest quarter op. profitDividend yieldArticles 30dSignals
PharmaResearch KOSDAQ₩62.6bn
+1% YoY
0.9%177Op. margin 20%+ Insider buying Major holder adding Dividend grower
T&L KOSDAQ₩21.7bn
+79% YoY
3.1%3Profit +50% Revenue & profit growth Op. margin 20%+ Dividend grower
Boditech Med KOSDAQ₩8.9bn
+35% YoY
–16Revenue & profit growth Major holder adding Insider selling Insider buying
BioNote KOSPI₩8.0bn
+66% YoY
3.8%8Profit +50% Op. margin 20%+
Wonbiogen KOSDAQ₩2.9bn
+22% YoY
2.2%8Op. margin 20%+ Dividend grower
Sewoonmedical KOSDAQ₩2.4bn
-36% YoY
–1Share pledge
Metabiomed KOSDAQ₩2.0bn
-61% YoY
2.1%0Dividend grower
Jetema KOSDAQ₩1.4bn
+39% YoY
–1Share pledge Major holder adding
GC Medical Science KOSDAQ₩1.1bn–1Insider buying
Optipharm KOSDAQ₩182m–4Turnaround Insider buying
HLB Panagene KOSDAQ−₩141m–184 quarters of losses
SCL Science KOSDAQ−₩190m–23Swung to loss Insider buying M&A / stake deal
PeopleBio KOSDAQ−₩502m–6Share pledge Split / consolidation 4 quarters of losses
Hass KOSDAQ−₩666m0.8%28Swung to loss Dividend cut
Nibec KOSDAQ−₩783m–21–
Korea Arlico Pharm KOSDAQ−₩802m
-148% YoY
1.7%3Swung to loss 4 quarters of losses
Gencurix KOSDAQ−₩820m–1Delisting / halt risk M&A / stake deal 4 quarters of losses
Celestra KOSDAQ−₩854m–04 quarters of losses
Asta KOSDAQ−₩1.0bn–5Control change Litigation 4 quarters of losses
Sugentech KOSDAQ−₩3.3bn–24 quarters of losses
Humasis KOSDAQ−₩3.5bn–104 quarters of losses
AbClon KOSDAQ−₩3.9bn–52Supply contract Clinical trial filing 4 quarters of losses
Bioneer KOSDAQ−₩4.0bn
-239% YoY
–15Swung to loss
HLB Life Science KOSDAQ−₩4.9bn–24 quarters of losses
ISU Abxis KOSDAQ−₩6.3bn–10Swung to loss
Rokit Healthcare KOSDAQ−₩9.5bn–111Swung to loss M&A / stake deal
HLB KOSDAQ−₩27.5bn–1664 quarters of losses
Seegene KOSDAQ–4.1%106Treasury share sale
Hans Biomed KOSDAQ––11–
Imgt KONEX––10–
Access Bio KOSDAQ––8Supply contract 4 quarters of losses
PCL KOSDAQ––7Delisting / halt risk

Industry codes are the primary business each company registered with DART and may not reflect its full business mix. Figures come from DART filings; prices are not included. Not investment advice.